Molecular and Cellular Biochemistry

, Volume 253, Issue 1–2, pp 269–285 | Cite as

Regulation of matrix metalloproteinases: An overview

  • Sajal Chakraborti
  • Malay Mandal
  • Sudip Das
  • Amritlal Mandal
  • Tapati Chakraborti


Matrix metalloproteinases (MMPs) are a major group of enzymes that regulate cell-matrix composition. MMP genes show a highly conserved modular structure. Ample evidence exists on the role of MMPs in normal and pathological processes, including embryogenesis, wound healing, inflammation, arthritis, cardiovascular diseases, pulmonary diseases and cancer. The expression patterns of MMPs have interesting implications for the use of MMP inhibitors as therapeutic agents. Insights might be gained as to the preference for a general MMP inhibitor as opposed to an inhibitor designed to be specific for certain MMP family members as it relates to a defined disease state, and may give clues to potential side effects. The signalling pathways that lead to induction of expression of MMPs are still incompletely understood, but certain patterns are beginning to emerge. Regarding inhibition of MMP expression at the level of kinase pathways, it is possible that selective chemical inhibitors for distinct signalling pathways (e.g. MAPK, PKC) will hopefully, soon be available for initial clinical trials. Overexpression of selective dual specificity MAPK phosphatases have been shown to prevent MMP promoter activation which could also be used as a novel strategy to prevent activation of AP-1 and ETS transcription factors and MMP promoters in vivo. Interactions between members of different transcription factors provide fine-tuning of the transcriptional regulation of MMP promoter activity. MMPs play a crucial role in tumor invasion. Although the expression of MMPs in malignancies has been studied widely, the specific role of distinct MMPs in the progression of cancer may be more complex than has been assumed. For example, it has recently been shown that MMP-3, MMP-7, MMP-9 and MMP-12 can generate angiostatin from plasminogen, indicating that their expression in peritumoral area may in fact serve to limit angiogenesis and thereby inhibit tumor growth and invasion. The recent view about the role of stromal cells in the progression of cancer cell growth and metastasis is particularly interesting, and additional studies about the regulation of MMP gene expression and activity in malignancies are needed to understand the role and regulation of MMPs in tumor cell invasion.

matrix metalloproteinases tissue inhibitors of metalloproteinases transcriptional regulation transcription factors gene expression nitric oxide mitogen activated protein kinases 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Chakraborti T, Das S, Mandal M, Mandal A, Chakraborti S: Role of Ca2+ dependent matrix metalloprotease-2 in stimulating Ca2+ ATPase activity under peroxynitrite treatment in pulmonary vascular smooth muscle plasma membrane. IUBMB Life 53: 167-173, 2002Google Scholar
  2. 2.
    Das S, Chakraborti T, Mandal M, Mandal A, Chakraborti S: Role of membrane-associated Ca2+ dependent matrix metalloprotease-2 in the oxidant activation of Ca2+ ATPase by tertiary butylhydroperoxide. Mol Cell Biochem 237: 85-93, 2002Google Scholar
  3. 3.
    Mandal M, Das S, Chakraborti T, Chakraborti S: Matrix metalloprotease 2-mediated activation of Ca2+-ATPase by superoxide radical (O2·) in plasma membrane of bovine pulmonary vascular smooth muscle. Ind J Biochem Biophys39: 390-396, 2002Google Scholar
  4. 4.
    Massova I, Kotra LP, Fridman R, Mobashery S: Matrix metalloproteinases: Structure evolution and diversification. FASEB J 12: 1075-1095, 1998Google Scholar
  5. 5.
    Woessner JF Jr: Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J 5: 2145-2154, 1991Google Scholar
  6. 6.
    Werb Z, Alexander CM, Adler RR: Expression and function of matrix metalloproteinases in development. In: H. Birkedal-Hansen, Z. Werb, H.G. Welgus, H.E. Van Wart (eds). Matrix Metalloproteinases and Inhibitors. Matrix Spec. Suppl. No. 1. Gustav Fischer, Stuttgart, 1992, pp 337-343Google Scholar
  7. 7.
    Twining SS: Regulation of proteolytic activity in tissues. Crit Rev Biochem Mol Biol 29: 315-383, 1994Google Scholar
  8. 8.
    Ravanti L, Kahari V-M: Matrix metalloproteinases in wound repair. Int J Mol Med 6: 391-407, 2000Google Scholar
  9. 9.
    Breathnach RL, Matrisian LM, Gensel MC, Staub A, Leroy P: Sequences coding for part of oncogene-induced transin are highly conserved in a ralated rat gene. Nucl Acids Res 15: 1139-1151, 1987Google Scholar
  10. 10.
    Collier IE, Wilhelm SM, Eisen AZ, Marmer BL, Grant GA, Seltzer JL, Kronberger A, He C, Bauer EA, Goldberg GI: H-ras oncogene-transformed human bronchial epithelial cells (TBE-1) secrete a single metalloprotease capable of degrading basement membrane collagen. J Biol Chem 263: 6579-6587, 1988Google Scholar
  11. 11.
    Huhtala P, Chow LT, Tryggvason K: Structure of the human type IV collagenase gene. J Biol Chem 265: 16485-16490, 1990Google Scholar
  12. 12.
    Spurr NK, Gough AC, Gosden J, Rout D, Porteous DJ, Heyningen VV, Docherty AJP: Restriction fragment length polymorphism analysis and assignment of the metalloproteinases stromelysin and collagenase to the long arm of chromosome 11. Genomics 2: 119-127, 1988Google Scholar
  13. 13.
    Huhtala P, Eddy RL, Fan YS, Byers MG, Shows TB, Tryggvason K: Completion of the primary structure of the human type IV collagenase preproenzyme and assignment of the gene (CLG4) to q21 region of chromosome 16. Genomics 6: 554-559, 1991Google Scholar
  14. 14.
    Girard MT, Matsubara M, Kublin C, Tessier MJ, Cintron C, Fini ME., Stromal fibroblasts synthesize collagenase and stromelysin during long-term connective tissue remodelling. J Cell Sci 104: 1001-1008, 1993Google Scholar
  15. 15.
    Fini ME, Girard MT: Expression of collagenolytic/gelatinolytic metalloproteinases by normal cornea. Invest Opthalmol Vis Sci 31: 1779-1784, 1990Google Scholar
  16. 16.
    Vine N, Powell JT: Metalloproteinases in degradating aortic disease. Clin Sci 81: 233-239, 1991Google Scholar
  17. 17.
    Heron GS, Unemori E, Wong M, Rapp JH, Hibbs MH, Stoney RJ: Connective tissue proteinases and inhibitors in abdominal aortic aneurysms. Arterioscler Thromb 11: 1667-1677, 1991Google Scholar
  18. 18.
    Denhardt DT, Feng B, Edwards DR, Cocuzzi ET, Malyankar UM: Tissue inhibitor of metalloproteinases (TIMP, aka EPA): Structure, control of expression and biological functions. Pharmacol Ther 59: 329-341, 1993Google Scholar
  19. 19.
    Woessner JF, Nagase HL: Matrix metalloproteinases and TIMPs. Oxford University Press, New York, 2000Google Scholar
  20. 20.
    Itoh Y, Ito A, Iwata K, Tanzawa K, Mori Y, Nagase H: Plasma membrane-bound tissue inhibitor of metalloproteinases (TIMP)-2 specifically inhibits matrix metalloproteinase-2 (gelatinase A) activated on the cell surface. J Biol Chem 273: 24360-24367, 1998Google Scholar
  21. 21.
    Imai K, Ohuchi E, Aoki T, Nomura H, Fujii Y: Membrane-type matrix metalloproteinase-1 is a gelatinolytic enzyme and is secreted in a complex with tissue inhibitor of metalloproteinase-2. Cancer Res. 56: 2707-2710, 1996Google Scholar
  22. 22.
    Yang Z, Kyriakides TR, Bornstein P: Matricellular proteins as modulators of cell-matrix interactions: Adhesive defect in thrombospodin-2-null fibroblasts is a consequence of increased levels of matrix metalloproteinase-2. Mol Biol Cell 11: 3353-3364, 2000Google Scholar
  23. 23.
    Yang Z, Strickland DK, Bornstein P: Extracellular MMP-2 levels are regulated by the low-density lipoprotein-related scavenger receptor and thrombospodin-2. J Biol Chem 276: 8403-8408, 2001Google Scholar
  24. 24.
    Barmina OY, Walling HW, Fiacco GJ, Freije JM, Lopez-Otin C: Collagenase-3 bids to aspecific receptor and requires the low density lipoprotein receptor-related protein for internalization. J Biol Chem 274: 30087-30093, 1999Google Scholar
  25. 25.
    Sternlicht MD, Werb Z: How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol 17: 463-516, 2001Google Scholar
  26. 26.
    Brooks PC, Stromblad S, Sanders LC, von Schalscha TL, Aimes RT, Stetler-Stevenson WG, Quigley JP, Cheresh DA: Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin alpha v beta 3. Cell 85: 683-693, 1996Google Scholar
  27. 27.
    Yu Q, Stamenkovic I: Cell surface localized matrix metalloprotease-9 proteolytically activate TGF-beta and promotes tumor invasion and angiogenesis. Genes Dev 14: 163-176, 2000Google Scholar
  28. 28.
    Yu WH, Woessner JF Jr: Heparan sulfate proteoglycans as extracellular docking molecules for matrilysin (of matrix metalloproteinase 7). J Biol Chem 275: 4183-4191, 2000Google Scholar
  29. 29.
    Wang Z, Jutterman R, Soloway PD: TIMP-2 is required for efficient activation of pro-MMP-2 in vivo. J Biol Chem 275: 26411-26415, 2000Google Scholar
  30. 30.
    Caterina JJ, Yamada S, Caterina MC, Longnecker G, Holmback K, Shi J, Yermovsky AE, Engler JA, Birkedal-Hansen H: Inactivating mutation of the mouse tissue inhibitor of metalloproteinase-2 (TIMP-2) gene alters proMMP-2 activation. J Biol Chem 275: 26416-26422, 2000Google Scholar
  31. 31.
    Saarialho-Kere U, Kovacs SO, Pentland AP, Olerud J, Welgus HG, Parks WC: Cell-matrix interaction modulates interstitial collagenase expression by human keratinocytes actively involved in wound healing. J Clin Invest 92: 2858-2866, 1993Google Scholar
  32. 32.
    Parks WC, Shapiro SD: Matrix metalloproteinases in lung biology. Respir Res 2: 10-19, 2001Google Scholar
  33. 33.
    Stetler-Stevension WG, Krutzsch HC, Liotta LA: Tissue inhibitor of metalloproteinases-2 (TIMP-2). A new member of the metalloproteinase inhibitor family. J Biol Chem 264: 17374-17378, 1989Google Scholar
  34. 34.
    Lelievre YR, Bouboutou J, Boiziau D, Faucher D, Achard D, Cartwright T: Low molecular weight, sequence based, collagenase inhibitors selectively block the interaction between collagenase and TIMP (tissue inhibitor of metalloproteinases). Matrix 10: 292-299, 1990Google Scholar
  35. 35.
    Howard EW, Bullen EC, Banda MJ: Regulation of the autoactivation of human 72-kDa progelatinase by tissue inhibitor of metalloproteinases-2. J Biol Chem 266: 13064-13069, 1991Google Scholar
  36. 36.
    Murphy G, Koklitis P, Carne AF: Dissociation of tissue inhibitor of metalloproteinases (TIMP) from enzyme complexes yields fully active inhibitor. Biochem J 261: 1031-1034, 1989Google Scholar
  37. 37.
    DeClerck YA, Yean TD, Lu HS, Ting J, Langley KE: Inhibition of autoproteolytic activation of interstitial procollagenase by recombinant metalloproteinase inhibitor MI/TIMP-2. J Biol Chem 266: 3893-3899, 1991Google Scholar
  38. 38.
    Mignatti P, Rifkin DB: Biology and biochemistry of proteinases in tumor invasion. Physiol Rev 73: 161-195, 1993Google Scholar
  39. 39.
    Kleiner DE Jr, Stetler-Stevenson WG: Structural biochemistry and activation of matrix metalloproteases. Curr Opin Cell Biol 5: 891-897, 1993Google Scholar
  40. 40.
    Lohi J, Lehti Jwestermarck VMK, Keski-Oja J: Regulation of membrane type matrix metalloprteanase-1 expression by growth factors and phorbol12-myristate. Eur J Biochem 239: 239-247, 1996Google Scholar
  41. 41.
    Knauper V, Will H, Lopez-Otin C, Smith B, Atkinson SJ, Stanton H, Hembrey RM, Murphy G: Cellular mechanism of human procollagenase-3 (MMP-13) activation: Evidence that MT1-MMP (MMP-14) and gelatinase A (MMP-2) are able to generate active enzyme. J Biol Chem 271: 17124-17131, 1996Google Scholar
  42. 42.
    Rajgopalan S, Meng XP, Ramasamy S, Harrison DG, Galis ZS: Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of the vascular metalloproteinases in vitro: Implication for atherosclerotic plaque stability. J Clin Invest 98: 2572-2579, 1996Google Scholar
  43. 43.
    Jovinge S, Ares MP, Kallin B, Nilsson J: Human monocytes/Mφ release TNF-α in response to Ox-LDL. Arterioscler Thromb Vasc Biol 16: 1573-1579, 1996Google Scholar
  44. 44.
    Weiss SJ, Pepper G, Ortiz X, Ragsdale C, Test ST: Oxidative activation of latent collagenase by human neutrophils. Science 227: 747-749, 1985Google Scholar
  45. 45.
    Galis ZS, Muszynski M, Sukhova GK, Simon-Morrissey E, Unemori EN, Lark MW, Amento E, Libby P: Cytokine stimulated human vascular smooth muscle cells synthesize a complement of enzymes required for extra cellular matrix digestion. Circ Res 75: 181-189, 1997Google Scholar
  46. 46.
    Springman EB, Angleton EL, Birkedal-Hansen H, Van Wart HE: Multiple modes of activation of latent human fibroblast collagenase: evidence for the role of a Cys73 active-site zinc-complex in latency and a 'cysteine switch' mechanism for activation. Proc Natl Acad Sci USA 87: 364-368, 1990Google Scholar
  47. 47.
    Van Wart HE, Birkedal-Hansen H: The cysteine switch: A principle of regulation of metalloproteinase activity with potential applicability to the entire matrix metalloproteinase gene family. Proc Natl Acad Sci USA 87: 5578-5582, 1990Google Scholar
  48. 48.
    Sellers A, Cartwright E, Murphy G, Reynolds JJ: Evidence that latent collagenases are enzyme-inhibitor complexes. Biochem J 163: 303-307, 1977Google Scholar
  49. 49.
    Murphy G, Sellers A: In: D.E. Woolley, J.M. Evanson (eds). Collagenases in Normal and Pathological Connective Tissues. Willy, New York, 1980, pp 65-81Google Scholar
  50. 50.
    Goldberg GI, Wilhelm SM, Kronberger A, Bauer EA, Grant GA, Eisen AZ: Human fibroblast collagenase. Complete primary structure and homology to an oncogene transformation-induced rat protein. J Biol Chem 261: 6600-6605, 1986Google Scholar
  51. 51.
    Stricklin GP, Jeffrey JJ, Roswit WT, Eisen AZ: Human skin fibroblast procollagenase: Mechanisms of activation by organomercurials and trypsin. Biochemistry 22: 61-68, 1983Google Scholar
  52. 52.
    Macartney HW, Tschesche H: Latent and active human polymorphonuclear leukocyte collagenases. Isolation, purification and characterisation. Eur J Biochem 130: 71-78, 1993Google Scholar
  53. 53.
    Macartney HW, Tschesche H: Lantent collagenase from human polymorphonuclear leucocytes and activation to collagenase by removal of a inhibitor. FEBS Lett 119: 327-332, 1980Google Scholar
  54. 54.
    Van Wart HE: Human neutrophil collagenase. Matrix 11(suppl): 31-36, 1992Google Scholar
  55. 55.
    Knauper V, Kramer S, Reinke H, Tschesche H: Characterization and activation of procollagenase from human polymorphonuclear leucocytes. N-terminal sequence determination of the proenzyme and various proteolytically activated forms. Eur J Biochem 189: 295-300, 1990Google Scholar
  56. 56.
    Weiss SJ, Peppin G, Ortiz X, Ragsdale C, Test ST: Oxidative autoactivation of latent collagenase by human neutrophils. Science 227: 747-749, 1985Google Scholar
  57. 57.
    Wize J, Abgarowicz T, Wojtecka-Lukasik E, Ksiezny S, Dancewicz AM: Activation of human leucocyte procollagenase by rheumatoid synovial tissue culture medium. Ann Rheum Dis 34: 520-523, 1975Google Scholar
  58. 58.
    Tyree B, Seltzer JL, Halme J, Jeffrey JJ, Eisen AZ: The stoichiometric activation of human skin fibroblast pro-collagenase by factors present in human skin and rat uterus. Arch Biochem Biophys 208: 440-443, 1981Google Scholar
  59. 59.
    Grant GA, Eisen AZ, Marmer BI, Roswit WT, Goldberg GI: The activation of human skin fibroblast procollagenase. Sequence identification of the major conversion products. J Biol Chem 262: 5886-5889, 1987Google Scholar
  60. 60.
    Peppin GJ, Weiss SJ: Activation of the endogenous metalloproteinase, gelatinase, by triggered human neutrophils. Proc Natl Acad Sci USA 83:4322-4326, 1986Google Scholar
  61. 61.
    Salo T, Lyons JG, Rahemtulla F, Birkedal-Hansen H, Larjava H: Transforming growth factor-β1 up-regulates type IV collagenase expression in cultured human keratinicytes. J Biol Chem 266: 11436-11441, 1991Google Scholar
  62. 62.
    Overall CM, Wrana JL, Sodek J: Transcriptional and post-transcriptional regulation of 72 kDa gelatinase/type IV collagenase by transforming growth factor-β1 in human fibroblasts. J Biol Chem 266: 14064-14071, 1991Google Scholar
  63. 63.
    Matrisian LM: Matrix metalloproteinase gene expression. Ann NY Acad Sci 734: 42-50, 1994Google Scholar
  64. 64.
    Delany AM, Brinckerhoff CE: Post-transcriptional regulation of collagenase and stromelysin gene expression by epidermal growth factor and dexamethasone in cultured human fibroblasts. J Cell Biochem 50: 400-410, 1992Google Scholar
  65. 65.
    Angel P, Baumann I, Stein B, Delius H, Rahmsdorf HJ, Herrlich P: 12-O-tetradecanoyl-phorbol-13-acetate induction of the human collagenase gene is mediated by an inducible enhancer element located in the 5′-flanking region. Mol Cell Biol 7: 2256-2266, 1987Google Scholar
  66. 66.
    Angel P, Imagawa M, Chiu R, Stein B, Imbra RJ, Rahmsford HJ, Jonat C, Herlich P, Karin M: Phorbol ester-inducible genes contain a common cis element recognized by a TPA modulated trans-acting factor. Cell 49: 729-739, 1987Google Scholar
  67. 67.
    Karin M, Liu ZG, Zandi F: Ap-1 function and regulation. Curr Opin Cell Biol 9: 240-246, 1997Google Scholar
  68. 68.
    Angel P, Karin M: The role of jun, fos and the AP-1 complex in cell proliferation and transformation. Biochim Biophys Acta 1072: 129-157, 1991Google Scholar
  69. 69.
    Schonthal A, Herrlich P, Rahmsford HJ, Ponta H: Requirement for fos gene expression in the transcriptional activation of collagenase by other oncogenes and phorbol esters. Cell 54: 325-334, 1988Google Scholar
  70. 70.
    Kerr LD, Holt JT, Matrisian LM: Growth factors regulate transin gene expression by c-fos-dependent abd c-fos-independent pathways. Science 242: 1424-1427, 1988Google Scholar
  71. 71.
    Lee JS, Sce RH, Deng T, Shi Y: Adenovirus E1A downregulates cjun-and JunB-mediated transcription by targeting their coactivator p. 300. Mol Cell Biol 16: 4312-4326, 1996Google Scholar
  72. 72.
    Doyle GAR, Pierce RA, Parks WC: Transcriptional induction of collagenase-1 in differentiated monocyte-like (U937) cells is regulated by AP-1 and an upstream C/EBP-β site. J Biol Chem 272: 11840-11849, 1997Google Scholar
  73. 73.
    Westermarck J, Seth A, Kahari V-M: Differential regulation of interstitial collagenase (MMP-1) gene expression by ETS transcription factors. Oncogene 14: 2651-2660, 1997Google Scholar
  74. 74.
    Benbow U, Brinckerhoff CE: The AP-1 site and MMP gene regulation: What is all the fuss about? Matrix Biol 15: 519-526, 1997Google Scholar
  75. 75.
    Sirum KL, Brinckerhoff CE: Cloning of the genes for human stromelysin and stromelysin 2: Differential expression in rheumatoid synovial fibroblasts. Biochemistry 28: 8691-8698, 1989Google Scholar
  76. 76.
    Auble DT, Brinckerhoff CE: The AP-1 sequence is necessary but not sufficient for phorbol induction of collagenase in fibroblasts. Biochemistry 30: 4629-4635, 1991Google Scholar
  77. 77.
    Vincenti MP, White LA, Schroen DJ, Benbow U, Brinckerhoff CE: Regulating expression of the gene for matrix metalloproteinase-1 (collagenase): Mechanism that control enzyme activity, transcription and mRNA stability. Crit Rev Eukaryol Gene Exp 6: 391-411, 1996Google Scholar
  78. 78.
    Chiu R, Angel P, Karin M: Jun-B differs in its biological properties from, and is a negative regulator of, c-Jun. Cell 59: 979-986, 1989Google Scholar
  79. 79.
    Bergelson S, Daniel V: Cooperative interaction between ETS and AP-1 transcription factors regulates induction of glutathione S-transferase Ya gene expression. Biochem Biophys Res Commun 200: 290-297, 1994Google Scholar
  80. 80.
    Westermarck J, Lohi J, Keski-Oja J, Kahari VM: Okadaic acid-elicited transcriptional activation of collagenase gene expression in HT-1080 fibrosarcoma cells is mediated by JunB. Cell Growth Diff 5: 1205-1213, 1994Google Scholar
  81. 81.
    Hu E, Mueller F, Oliviero S, Papaioannou VE, Johnson R, Spiegelman BM: Targeted disruption of the c-fos gene demonstrates c-fos-dependent and-independent pathways for gene expression stimulated by growth factors or oncogenes. EMBO J 13: 3094-3103, 1994Google Scholar
  82. 82.
    Saez E, Rutberg SE, Mueller F, Oppenheim H, Smoluk J, Yuspa SH, Spiegelman BM: c-fos is required for malignant progression of skin tumors. Cell 82: 721-732, 1995Google Scholar
  83. 83.
    Gack S, Vallon R, Schaper J, Ruther U, Angel P: Phenotypic alterations in fos-transgenic mice correlate with changes in Fos/Jun-dependent collagenase type-1 expression. Regulation of mouse metalloproteinases by carcinogens, tumor promoters, cAMP, and Fos oncoprotein. J Biol Chem 269: 10263-10369, 1994Google Scholar
  84. 84.
    Levin WJ, Press MF, Gaynor RB, Sukhatme VP, Boone TC, Reissmann PT, Figlin RA, Holmes EC, Souza LM, Slamon DJ: Expression patterns of immediate early transcription factors in human non-small cell lung cancer. The Lung Cancer Study Group. Oncogene 11: 1261-1269, 1995Google Scholar
  85. 85.
    Westermarck J, Kahari V-M: Regulation of matrix metalloproteinase expression in tumor invasion. FASEB J 13: 781-792, 1999Google Scholar
  86. 86.
    Quinones S, Saus J, Otani Y, Harris ED Jr, Kurkinen M: Transcriptional regulation of human stromelysin. J Biol Chem 264: 8339-8344, 1989Google Scholar
  87. 87.
    Jonat G, Rahmsdorf HJ, Park K-K, Cato ACB, Gebel S, Ponta H, Herrlich P: Antitumor promotion and antiinflammation: Down-modulation of AP-1 (Fos/Jun) activity by glucocorticoid hormone. Cell 62: 1189-1204, 1990Google Scholar
  88. 88.
    Yang-Yen HF, Chambard JC, Sun YL, Smeal T, Schmidt TJ, Drouin H, Karin M: Transcriptional interference between c-Jun and the glucocorticoid receptor: Mutual inhibition of DNA binding due to direct protein-protein interaction. Cell 62: 1205-1215, 1990Google Scholar
  89. 89.
    Schule R, Rangarajan P, Kliewer S, Ransone LJ, Bolado J, Yang N, Verma IM, Evans RM: Functional antagonism between oncoprotein c-jun and glucocorticoid receptor. Cell 62: 1217-1226, 1990Google Scholar
  90. 90.
    Baxter JD, Funder JW: Hormone receptors. N Engl J Med 301: 1149-1161, 1979Google Scholar
  91. 91.
    Russell SB, Trupin JS, Myers JC, Broquist AH, Smith JC, Myles ME, Russell JD: Differential glucocorticoid regulation of collagen mRNAs in human dermal fibroblasts. Keloid-derived and fetal fibroblasts are refractory to down-regulation. J Biol Chem 264: 13730-13735, 1989Google Scholar
  92. 92.
    Sharrocks AD, Brown AL, Ling Y, Yates PR: The ETS-domain transcription factor family. Int J Biochem Cell Biol 12: 1371-1387, 1997Google Scholar
  93. 93.
    Carrere S, Verger A, Flourens A, Stehelin D, Duterque-Coquillaud M: Erg proteins, transcription factors of the Ets family form homo, heterodimers and ternery complexes via two distinct domains. Oncogene 16: 3261-3268, 1998Google Scholar
  94. 94.
    McDonnell SE, Kerr LD, Matrisian LM: Epidermal growth factor stimulation of stromelysin mRNA in rat fibroblasts requires induction of proto-oncogenes c-fos and c-jun and activation of protein kinase C. Mol Cell Biol 10: 4284-4293, 1990Google Scholar
  95. 95.
    Machida CM, Scott JD, Ciment G: NGF-induction of the metalloproteinase transin/stromelysin in PC12 cells: Involvement of multiple protein kinases. J Cell Biol 114: 1037-1048, 1991Google Scholar
  96. 96.
    Kim S-J, Lafyatis R, Kim KY, Angel P, Fujiki H, Karin M, Sporn MB, Roberts AB: Regulation of collagenase gene expression by okadaic acid, an inhibitor of protein phosphatases. Cell Reg: 269-278, 1990Google Scholar
  97. 97.
    Angel P, Karin M: Specific members of the jun protein family regulate collagenase expression in response to various extracellular stimuli. In: H. Birkedal-Hansen, Z. Werb, H.G. Welgus, H.E. Van Wart (eds). Matrix Metalloproteinase and Inhibitors. Matrix Spec. Suppl. No. 1. Gustav Fischer, Stuttgart, 1992, pp 156-164Google Scholar
  98. 98.
    Minden A, Karin M: Regulation and function of the JNK subgroup of Map kinases. Biochim Biophys Acta 1333: F85-F104, 1997Google Scholar
  99. 99.
    Robinson MJ, Cobb MH: Mitogen-activated protein kinase pathways. Curr Opin Cell Biol 9: 180-186, 1997Google Scholar
  100. 100.
    Lewis TS, Shapiro PS, Ahn NG: Signal transduction through Map kinase cascades. Adv Cancer Res 74: 49-129, 1998Google Scholar
  101. 101.
    Mansour SJ, Matten WT, Hermann AS, Candia JM, Rong S, Fukasawa K, Vande Woude GF, Ahn NG: Transformation of mammalian cells by constitutively active MAP kinase kinase. Science 265: 966-970, 1994Google Scholar
  102. 102.
    Cowley S, Paterson H, Kemp P, Marshall CJ: Activation of Map kinase kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH 3T3 cells. Cell 77: 841-852, 1994Google Scholar
  103. 103.
    Sivraman V, Wang H, Nuovo G, Malbon C: Hyperactivation of mitogen-activated protein kinase in human breast cancer. J Clin Invest 99: 1478-1483, 1997Google Scholar
  104. 104.
    Khosravi-Far R, Campbell S, Rossman KL, Der CJ: Increasing complexity of Ras signal transduction: Involvement of Rho family proteins. Adv Cancer Res 72: 57-107, 1998Google Scholar
  105. 105.
    Leppa S, Saffrich R, Ansorge W, Bohmann D: Differential regulation of c-jun by ERK and JNK during PC12 cell differentiation. EMBO J 17: 4404-4413, 1998Google Scholar
  106. 106.
    O'Hagan RC, Tozer RG, Symons M, McCormick F, Hassell JA: The activity of the Ets transcription factor PEA3 is regulated by two distinct MAPK cascades. Oncogene 113: 1323-1333, 1996Google Scholar
  107. 107.
    Whitmarsh AJ, Cavanagh J, Tournier C, Yasuda J, Davis RJ: A mammalian scaffold complex that selectively mediates MAP kinase activation. Science 281: 1671-1674, 1998Google Scholar
  108. 108.
    Schaeffer HJ, Catling AD, Eblen ST, Collier LS, Krauss A, Weber MJ: MP1: A MEK binding partner that enhances enzymatic activation of the MAP kinase cascade. Science 281: 1668-1371, 1998Google Scholar
  109. 109.
    Frost JA, Geppert TD, Cobb MH, Feramisco JR: A requirement for extracellular signal-regulated kinase (ERK) function in the activation of AP-1 by Ha-Ras, phorbol 12-myristate 13-acetate, and serum. Proc Natl Acad Sci USA 91: 3844-3848, 1994Google Scholar
  110. 110.
    Rutter GA, White MR, Tavare JM: Involvement of MAP kinase in insulin signalling revealed by non-invasive imaging of luciferase gene expression in single living cells. Curr Biol 5: 890-899, 1995Google Scholar
  111. 111.
    Reunanen N, Westermarck J, Hakkinen L, Holmstrom Th, Elo I, Eriksson JE, Kahari V-M: Enhancement of fibroblast collagenase (matrix metalloproteinase-1) gene expression by ceramide is mediated by extracellular signal-regulated and stress-activated protein kinase pathways. J Biol Chem 273: 5137-5145, 1998Google Scholar
  112. 112.
    Westermarck J, Holmstrom TH, Ahonen M, Ericsson JE, Kahari V-M: Enhancement of collagenase-1 (MMP-1) gene expression by tumor promoter okadaic acid is mediated by stress-activated protein kinase Jun N-terminal kinase and p38. Matrix Biol 17: 547-557, 1998Google Scholar
  113. 113.
    Ridley SH, Sarsfield SJ, Lee JC, Bigg HF, Cawston TE, Taylor DJ, DeWitt DL, Saklatvala J: Actions of IL-1 are selectively controlled by p38 mitogen activated protein kinase: Regulation of prostaglandin H synthase-2, metalloproteinases, and IL-6 at different levels. J Immunol 158: 3165-3173, 1997Google Scholar
  114. 114.
    Jenkins GM, Crow MT, Bilato C, Gluzband Y, Ryu WS, Li Z, Stetler-Stevenson W, Nater C, Froelich JP, Lakatta EG, Cheng L: Increased expression of membrane-type matrix metalloproteinase and preferential localization of matrix metalloproteinase-2 to the neointima of the balloon-injured rat carotid arteries. Circulation 97: 82-90, 1998Google Scholar
  115. 115.
    Dollery CM, McEwan JR, Wang M, Sang QA, Liu Y, Shi YE: TIMP-4 is regulated by vascular injury in rats. Circ Res 84: 498-504, 1999Google Scholar
  116. 116.
    Gurjar MV, Sharma RV, Bhalla RC: eNOS gene transfer inhibits smooth muscle cell migration and MMP-2 and MMP-9 activity. Arterioscler Thromb Vasc Biol 19: 2871-2877, 1999Google Scholar
  117. 117.
    Owens MW, Milligan SA, Jourd'heuil D, Grisham MB: Effects of reactive metabolites of oxygen and nitrogen on gelatinase A activity. Am J Physiol 273: L445-L450, 1997Google Scholar
  118. 118.
    Kleiner DE Jr, Tuuttila A, Tryggvason K, Stetler-Stevenson WG: Stability analysis of latent and active 72-kDa type IV collagenase: The role of tissue inhibitor of metalloproteinases-2 (TIMP-2). Biochemistry 32: 1583-1592, 1993Google Scholar
  119. 119.
    Willenbrock F, Crabbe T, Slocombe PM, Sutton CW, Docherty AJ, Cockett MI, O'Shea M, Brocklehurst K, Phillips IR, Murphy G: The activity of the tissue inhibitors of the metalloproteinases is regulated by C-terminal domain interactions: A kinetic analysis of the inhibition of gelatinase A. Biochemistry 32: 4330-4337, 1993Google Scholar
  120. 120.
    Heath JK, Reynolds JJ, Meikle MC: Osteopetrotic (grey-lethal) bone produces collagenase and TIMP in organ culture: Regulation by vitamin A. Biochem Biophys Res Commun 168: 1171-1176, 1990Google Scholar
  121. 121.
    Sotturp-Jensen L: α-macroglobulins: Structure, shape and mechanism of proteinase complex formation. J Biol Chem 264: 11539-11542, 1989Google Scholar
  122. 122.
    Birkedal-Hansen H, Moore WGI, Bodden MK, Windsor LJ, Birkedal-Hansen B, DeCarlo A, Engler JA: Matrix metalloproteinase: A review. Crit Rev Oral Biol Med 4: 197-250, 1993Google Scholar
  123. 123.
    Cui W, Fowlis DJ, Bryson S, Duffic E, Ireland H, Balmain A, Akhurst RJ: TGF-β1 inhibits the formation of benign skin tumors, but enhances progression to invasive spindle carcinomas in transgenic mice. Cell 86: 531-542, 1996Google Scholar
  124. 124.
    Westermarck J, Hakkinen L, Fiers W, Kahari V-M: TNF-R55-specific form of human tumor necrosis factor-α induces collagenase gene expression by human skin fibroblasts. J Invest Dermatol 105: 197-202, 1995Google Scholar
  125. 125.
    Monia BP, Johnston JF, Geiger T, Muller T, Fabro D: Antitumor activity of phosphorothioate antisense oligodeoxynucleotide targeted against C-raf kinase. Nat Med 2: 668-675, 1996Google Scholar
  126. 126.
    Gum R, Wang H, Lengyel E, Juarez J, Boyd D: Regulation of 92 kDa type IV collagenase expression of the jun aminoterminal kinase and the extracellular signal-regulated kinase-dependent signaling cascades. Oncogene 14: 1481-1493, 1997Google Scholar
  127. 127.
    Buttice G, Duterque Coquillaud M, Basuyaux JP, Carrere S, Kurkinen M, Stehelin D: Erg, an Ets family member, differentially regulates human collagenase 1 (MMP-1) and Stromelysin (MMP3) gene expression by physically interacting with the fos/jun complex. Oncogene 13: 2279-2306, 1996Google Scholar
  128. 128.
    Shiozawa S, Shimizu K, Tanaka K, Hino K: Studies on the contribution of c-fos/AP-1 to arthritic joint disruption. J Clin Invest 99: 1210-1216, 1997Google Scholar
  129. 129.
    Huang C, Ma WY, Dawson MI, Rincon M, Flavell RA, Ong Z: Blocking activators protein-1 activity, but not activating retinoic acid response element, is required for the antitumor promotion effect of retinoic acid. Proc Natl Acad Sci USA 94: 5826-5830, 1997Google Scholar
  130. 130.
    Hua J, Muschel RJ: Inhibition of matrix metalloproteinase-9 expression by a ribozyme blocks metastasis in a rat sarcoma model system. Cancer Res 56: 5279-5284, 1996Google Scholar
  131. 131.
    Gasegawa S, Koshikawa N, Momiyama N, Moriyama K, Ichikawa Y, Ishikawa T, Mitsubishi M, Shimada H, Miyazaki K: Matrilysin-specific antisense oligonucleotide inhibits liver metastasis of human colon cancer cells in a nude mice model. Int J Cancer 76: 812-816, 1998Google Scholar
  132. 132.
    Li YT, Mctiernan CF, Feldman AM: Interplay of matrix metallo-proteinases, tissue inhibitors of metalloproteinases and their regulators in cardiac matrix remodeling. Cardiovasc Res 46: 214-224, 2000Google Scholar

Copyright information

© Kluwer Academic Publishers 2003

Authors and Affiliations

  • Sajal Chakraborti
    • 1
  • Malay Mandal
    • 1
  • Sudip Das
    • 1
  • Amritlal Mandal
    • 1
  • Tapati Chakraborti
    • 1
  1. 1.Department of Biochemistry and BiophysicsUniversity of KalyaniKalyani West BengalIndia

Personalised recommendations